CNMD

CONMED Corporation

$51.21

-1.41%
SectorHealthcareIndustryMedical DevicesCountryUnited States

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.

Source: Yahoo Finance
AI summary

Price & performance

1M+15.8%
3M+6.5%
YTD+32.4%
1Y+17.4%
52-week range—
Beta0.90
Full chart and returns against a benchmark

Q-Score

56/ 100

Quality against peers; 50 is the peer median.

Growth45
Risk62
Performance37
Valuation72
Profitability65
Leverage50
Sentiment27
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.4B+5.2%
Net income$47.1M-64.5%
Net margin3.4%-6.7 pts
Historical fundamentals

Valuation

CNMDIndustryP/E20.7829.61P/S1.113.49EV/EBITDA15.1018.38P/B1.443.39PEG1.421.42
Dividend yield0.41%
Every valuation metric

Earnings

Jan 27next report, after the close
EPS estimate$1.00
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate